Avant Diagnostics Inc.

Avant Diagnostics Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$9.43 M
Shares Outstanding
336.96 M
Public Float
321.6 M

Profile

Address
1050 30th Street NW
Washington District of Columbia 20007
United States
Employees -
Website http://www.avantdiagnostics.com
Updated 09/14/2018
Avant Diagnostics, Inc. is a medical technology company, which engages in the research of human genome sequencing project. It also develops the OvaDx screening test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. The company is headquartered in Scottsdale, AZ.

Financials

View All

Jeffrey Mark Busch
Chairman
Michael I. Ruxin
President, Chief Executive Officer & Director